Mohammad J Siddiqui

Dr. Mohammad J Siddiqui

International Islamic University Malaysia
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2012 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
EMElsnoussi Ali Hussin Mohamed
Elsnoussi Ali Hussin Mohamed
Mohammad J SiddiquiMohammad J Siddiqui
Mohammad J Siddiqui
LALee Fung Ang
Lee Fung Ang
ASAmirin Sadikun
Amirin Sadikun
SCSue Hay Chan
Sue Hay Chan
MYMun Fei Yam
Mun Fei Yam
In the present study, we tested a 50% ethanolic extract of Orthosiphon stamineus plants and its isolated bioactive compound with respect to their α-glucosidase and α-amylase inhibitory activities.

1 January 2012 in Nutrition and Cancer
Verified
Journal Article
Closed access
MBMohamed Khadeer Ahamed Basheer
Mohamed Khadeer Ahamed Basheer
AAAbdalrahim F. A. Aisha
Abdalrahim F. A. Aisha
ZNZeyad Nassar
Zeyad Nassar
Mohammad J SiddiquiMohammad J Siddiqui
Mohammad J Siddiqui
ZIZ. Ismail
Z. Ismail
AMAman Shah Majid
Aman Shah Majid
Cat's whiskers (Orthosiphon stamineus) is commonly used as Java tea to treat kidney stones including a variety of angiogenesis-dependent diseases such as tumorous edema, rheumatism, diabetic blindness, and obesity. In the present study, antitumor potential of standardized 50% ethanol extract of O. stamineus leaves (EOS) was evaluated against colorectal tumor in athymic mice and antiangiogenic efficacy of EOS was investigated in human umbilical vein endothelial cells (HUVEC). EOS at 100 mg/kg caused 47.62 ± 6.4% suppression in tumor growth, while at 200 mg/kg it caused 83.39 ± 4.1% tumor regression. Tumor histology revealed significant reduction in extent of vascularization. Enzyme-linked immunosorbent assay showed EOS (200 mg/kg) significantly reduced the vascular endothelial growth factor (VEGF) level in vitro (211 ± 0.26 pg/ml cell lysate) as well as in vivo (90.9 ± 2 pg/g tissue homogenate) when compared to the control (378 ± 5 and 135.5 ± 4 pg, respectively). However, EOS was found to be noncytotoxic to colon cancer and endothelial cells. In vitro, EOS significantly inhibited the migration and tube formation of human umbilical vein endothelial cells (HUVECs). EOS suppressed VEGF-induced phosphorylation of VEGF receptor-2 in HUVECs. High performance liquid chromatography (HPLC) analysis of EOS showed high rosmarinic acid contents, whereas phytochemical analysis revealed high protein and phenolic contents. These results demonstrated that the antitumor activity of EOS may be due to its VEGF-targeted antiangiogenicity.

1 January 2018 in Journal of Pharmacy and Bioallied Sciences
Verified
Journal Article
Open access
PDF file
Mohammad J SiddiquiMohammad J Siddiqui
Mohammad J Siddiqui
MSMohammed Saleh
Mohammed Saleh
SBSiti N B Binti Basharuddin
Siti N B Binti Basharuddin
SZSiti H Binti Zamri
Siti H Binti Zamri
MNMohd H bin Mohd Najib
Mohd H bin Mohd Najib
AKAlfi Khatib
Alfi Khatib
Saffron, Crocus sativus (Iridaceae), is a perennial herb, which earned its popularity as both medicine and spice. It is an inhabitant of different mountainous regions of Asia Minor to Greece, Western Asia, Egypt, and India. The benefits of saffron as an antidepressant are well-documented. Almost 150 volatile and nonvolatile compounds are obtained from the chemical analysis of this plant. Fewer than 50 constituents elucidated and identified so far showed phytochemical characteristics. The major bioactive compounds identified are safranal, crocin, and picrocrocin, which are responsible for its aroma as well as its bitter taste. This review is an attempt to encompass the methods of analysis and pharmacodynamic and pharmacokinetic properties of saffron followed by its efficacious and safe potential.

1 May 2004 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
RMRama Mukherjee
Rama Mukherjee
MJManu Jaggi
Manu Jaggi
PRPraveen Rajendran
Praveen Rajendran
Mohammad J SiddiquiMohammad J Siddiqui
Mohammad J Siddiqui
SSSanjay K Srivastava
Sanjay K Srivastava
ABAnand C Burman
Anand C Burman

24 November 2020 in Molecules
Verified
Journal Article
Open access
PDF file
QAQamar Uddin Ahmed
Qamar Uddin Ahmed
AAAbdul Hasib Mohd Ali
Abdul Hasib Mohd Ali
SMSayeed Mukhtar
Sayeed Mukhtar
MAMeshari A. Alsharif
Meshari A. Alsharif
HPHumaira Parveen
Humaira Parveen
AAAlhassan Muhammad Alhassan
Alhassan Muhammad Alhassan
In recent years, there is emerging evidence that isoflavonoids, either dietary or obtained from traditional medicinal plants, could play an important role as a supplementary drug in the management of type 2 diabetes mellitus (T2DM) due to their reported pronounced biological effects in relation to multiple metabolic factors associated with diabetes. Hence, in this regard, we have comprehensively reviewed the potential biological effects of isoflavonoids, particularly biochanin A, genistein, daidzein, glycitein, and formononetin on metabolic disorders and long-term complications induced by T2DM in order to understand whether they can be future candidates as a safe antidiabetic agent. Based on in-depth in vitro and in vivo studies evaluations, isoflavonoids have been found to activate gene expression through the stimulation of peroxisome proliferator-activated receptors (PPARs) (α, γ), modulate carbohydrate metabolism, regulate hyperglycemia, induce dyslipidemia, lessen insulin resistance, and modify adipocyte differentiation and tissue metabolism. Moreover, these natural compounds have also been found to attenuate oxidative stress through the oxidative signaling process and inflammatory mechanism. Hence, isoflavonoids have been envisioned to be able to prevent and slow down the progression of long-term diabetes complications including cardiovascular disease, nephropathy, neuropathy, and retinopathy. Further thoroughgoing investigations in human clinical studies are strongly recommended to obtain the optimum and specific dose and regimen required for supplementation with isoflavonoids and derivatives in diabetic patients.

11 June 2014 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
SJShazia Jamshed
Shazia Jamshed
Ramadan M. ElkalmiRamadan M. Elkalmi
Ramadan M. Elkalmi
Kingston RajiahKingston Rajiah
Kingston Rajiah
AAAbdul Kareem Al-Shami
Abdul Kareem Al-Shami
SSSiti Hadijah Shamsudin
Siti Hadijah Shamsudin
SZSiti Maryam Bt Zamri
Siti Maryam Bt Zamri
Introduction: This study is aimed to investigate the understanding of antibiotic use and antibiotic resistance and its correlate factors among final-year medical and pharmacy students at International Islamic University Malaysia (IIUM). Methodology: This was a cross-sectional study. The study instrument was developed by extensive literature search and was subjected to face validity and content validity to medical and pharmacy academics. A pilot study was conducted to ascertain the reliability coefficient. Data was entered to SPSS version 17 and descriptive and inferential statistics were applied. Results: A total of 123 questionnaires were included in the study. Out of 123 respondents, 58.5% (n = 72) were final-year medical students, while 41.5% (n = 51) were final-year pharmacy students. The majority of the respondents showed adequate knowledge regarding the course contents related to antibiotics (n = 116; 94.3%). Almost all the respondents correctly reported the difference between bactericidal and bacteriostatic antibiotics. Only 15.4% (n = 19) and 27.6% (n = 34) of students were able to recognize Streptococcus pyogenes as non-pencillin resistant bacterium and Enterococcus as vancomycin-resistant bacterium, respectively. Conclusions: The students showed good understanding regarding antibiotic resistance. In comparison to medical students, pharmacy students showed better understanding and more adequate knowledge, as the mean value for each domain was slightly higher for pharmacy students. Extensively improving the curriculum and educating healthcare professionals, especially physicians and pharmacists, right from the time of their educational training can inculcate a moral responsibility toward the judicious use of antibiotics, which can serve to eradicate antibiotic resistance.